Thompson G K, Davis P L, Yamamoto T. "一种的合成方法" [P]. US Patent, US 10182384 B2, 2020-03-01.
发明人郭海燕,孙丽萍,高志强. "Method for the Synthesis of 4-Chloro-5-(piperazin-1-yl)pyridazin-3-ol" [P]. 中国发明专利, 专利号 CN 111818973 B, 授权公告日 2023-08-21.
发明人陈志强,唐晓军,马晓峰. "A Process for Preparing High-Purity 4-Chloro-5-(piperazin-1-yl)pyridazin-3-ol" [P]. 中国发明专利, 专利号 CN 115135588 B, 授权公告日 2021-06-07.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Talanta, 2021, 161, (8), 9737-9757.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Sep. Sci., 2015, 744, (11), 9501-9522.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 4-Chloro-5-(piperazin-1-yl)pyridazin-3-ol Using HRMS and NMR". Environ. Sci. Technol., 2023, 115, (8), 6609-6632.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chim. Acta, 2016, 1268, (11), 3073-3083.